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another explanation for the lack of reactive pulmonary
arterial hypertension.
pulmonary capillary wedge mean (PCWP) or pulmonary
artery diastolic pressure '(PADP) is a useful guide to LV
end-diastolic pressure in patients with congestive cardio-
myopathy and constrictive pericarditis: serial measure-
ment of right heart pressures may be of value in the
management of critically ill patients with these disorders.
This study was supported by grants from the South African
Medical Research Council and Anglo American Corporation
of South Africa.
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Gonadal Irradiation
E. E. D. MILLS
SUMMARY
A brief account is given of the circumstances under which
gonadal irradiation may be expected to occur. The non-
specific tissue effect and the hormonal and sterilising
effects are considered. Genetic implications are men-
tioned.
S. Afr. Med. J., 48, 543 (1974).
For the general practitioner inexorably implicated in the
management of the patient suffering from malignant
disease, a basic knowledge of the effects of ionising irra-
diation on the human organism is desirable. This is
probably even more so in the specific instance of gonadal
irradiation effects. There is little justification in ignoring
or underplaying the psychological trauma and the anxiety
experienced by the patient who knowingly submits to radia-
tion exposure. Furthermore, the practitioner should be
in a position to warn the patient of the real risk of
sterility or castration. For this reason the radiotherapist
must lean heavily on the support of his general practitioner
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colleague in the management of the patient (and his spouse)
when recommending treatment with ionising irradiation.
RADIATION EXPOSURE
The circumstances of exposure include:
1. Accidental or occupational exposure to radiation.
When this occurs the effects will be dependent on over-all
radiation dose and duration of exposure.
2. Radiation therapy for malignancies of the primary
sex organs and closely related neighbouring structures.
Those tissues directly in the radiation volume will receive
a full cell-killing dose of irradiation.
3. Radiotherapy administered for disease of remote
regions. The dose will be the consequence of scattered
irradiation and will depend on distance from the primary
beam.' Considering a treatment field of 20 by 15 cm the
scattered dose at 5 cm ~ 5%, at 15 cm ~ 0,7% and at
25 cm ~ 0,5%. For example in a woman receiving 5000
rads to a mediastinal field the dose to the ovaries would
be 20 rads. In the case of the male receiving 5 000 rads
to retroperitoneal nodes the testicular dose would be as
high as 150 - 200 rads. This will result in some degree of
temporary aspermia. (Doses above 600 rads will cause
permanent sterility.)'
4. Radiation as an alternative to surgical castration. As
discussed later, this is only practical in the female.
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5. Radiation from circulating radioactive isotopes used
therapeutically, as in thyroid disease. The dose to the
gonads is small and can be disregarded.
RADIATION EFFECTS
The effect of gonadal irradiation can be considered in
three different contexts: (i) the non-specific tissue effects;
(ii) the sterilising effect and its hormonal consequences;
and (iii) the genetic effects.
Non-specific Radiation Change in the Primary Sex
Organs
The non-specific response of the pelvic structures, like
that of other tissues, depends on a number of factors, sum-
marised as follows:
. Radiation factors: These include the total dose adminis-
tered; total treatment time; the volume of tissue treated
and the radiation distributed within that volume.
Use of adjnvants, such as chemotherapeutic agents
(potentiators) and hyperbaric oxygen.
Patient factors, including age; race; nutritional state; the
tissue oxygenation (degree of vascularity and the haemo-
globin concentration); and previous treatment (surgery or
radiotherapy) received.
It is therefore often difficult or unreliable to anticipate
a given reaction in a given patient or to assess tolerance
prior to curative therapy such as may be used in a treat-
ment programme of 5 500 rads given over 5f weeks in
equal daily fractions.
Specific Radiation Changes in Primary Sex Organs
Cervix and Corpus Uteri
The tissues composing the cervix and uterus are able to
tolerate very high doses of radiation, much more so than
any other comparable volume of tissue anywhere else in
the body. The epithelium of the uterus and cervix appears
to possess a remarkable ability to recover from radiation
injury even at doses of 15000 to 20000 rads from an
adjacent radium source. This is well in excess of a tumoro-
cidal dose and it is for this reason that the small cervical
carcinoma is so readily controlled by use of intracavitary
radium.
Indolent postirradiation ulcers of the cervix and vaginal
vault can be expected to develop 6 - 12 months later in a
small percentage of patients. These ulcers, however, most
often follow on the successful treatment of what were large
ulcerating cancers. They are often asymptomatic and dif-
ficult to distinguish from persistent or recurrent disease.
Months may be required for re-epithelisation, especially
where there is repeated coital trauma. There is also a real.
danger that such ulceration may develop into vesicovaginal
or rectovaginal fistulas. Conservative management usually
proves successful.
The Testes
The testicle, because of its accessibility and variety of
cell types of widely varying radiosensitivity, has for many
years been a favourite site of study among radiobiologists.
In spite of this the data on the radiation effect on sperma-
togenesis in man is very scanty.
Such information as we have is largely based on semen
counts done on patients undergoing radiation therapy for
some malignant disease, while data derived from accidental
exposure' and incidents such as the Hiroshima bombing,
were based on reproductive performance. Semen counts
have been so poorly documented as to be useless for
analyses. We must therefore rely on the results of animal
experimentation and the assumption that these can to
some degree be extrapolated to humans.
The three cell types involved in normal spermatogenesis
are: (a) the cells of Leydig or the interstitial cells, which
are responsible for testosterone and the control of the
secondary sex organs and characteristics; (b) the syncytial
cells of Sertoli, which are responsible for the support and
nutrition of the developing sperm; and (c) the germ cell.
The spermatogonia which derive from the gonocytes of
the fetus and infant are the stem cells of the adult semini-
ferous tubules and are seen as the basal cell layer com-
prising the cell column of the tubule. They divide by
mitosis, resulting in the next layer of cells - the primary
spermatocytes. These then undergo reduction division,
called meiosis, by which the normal diploid number of 46
chromosomes is reduced to the haploid number of 23, and
so are transformed into secondary spermatocytes. These
in turn undergo a normal mitotic division to form two
spermatoids, which mature by a series of morphological
steps to spermatozoa. The duration of this entire process
has been estimated as being about 40 days in the mouse
and 64 days in the human. .
What happens when these tissues are irradiated depends
on where in the spermatogenic pathway the particular cell
is, because the degree of radiosensitivity varies throughout
the sequence of the maturation process. In terms of the
cell-killing effect of irradiation, those cells undergoing
division either by mitosis or meiosis show the least degree
of radiation tolerance.
This can be readily demonstrated histologically. Two
hours after irradiation the spermatogenetic cell column
starts to shrink because of a reduction in the number of
spermatogonia, some of which are undergoing abnormal
mitosis.
Four days later we find the more mature elements, the
spermatozoa and spermatids, unchanged. This means that
the process of maturation has continued without replace-
ment by the stem cell or spermatogonia, which have
disappeared, resulting in a depletion of primary spermato-
cytes which also show abnormal division. Associated with
reduction in cell population is a more marked shrinkage
of the cell column. Eight days after irradiation all primary
spermatocytes have disappeared and some secondary sper-
matocytes show abnormal mitosis, with further reduction
of the cell column.
Three weeks after irradiation no spermatocytes are left
and a few of the spermatids show abnormally-shapea
heads. The cell column is further reduced. At 5 weeks no
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spermatids are left and all that remains are the Sertoli'
cells and new spermatogonia showing that recovery has
begun. This has been shown to occur as late as 2 - 3 years
after radiation exposure in the human testes:
It follows, therefore, that sperm production will con-
tinue for some time after testicular irradiation, but that
this will be followed by a period of aspermia which may
be complete or incomplete, of short or long duration,
depending on the total radiation dose. When repopulation
occurs it takes approximately three times as long as nor-
mal spermatogenesis:
It must be remembered that neither the severity of nor
the rate of recovery from the radiation effect is altered by
hormone administration before, during or after exposure.
During the period of aspermia neither the interstitial hor-
mone-producing cells nor the syncytial cells of Sertoli
appear to be affected. In the fetus or infant, however,
these interstitial cells are still undergoing proliferation and
because of their immaturity are more sensitive to the
effects of ionising irradiation. As a result their growth is
suppressed, and the adult will be hormonally deficient.
In the adult, however, even in the presence of complete
or permanent aspermia, there is no gross regression of
sec.ondary sex characteristics. This emphasises the dif-
ference between surgical and X-ray castration. A difference
based on the fact that although spermatogenesis is hor-
monally controlled (by the pituitary and by the androgen
production of the Leydig cells), the germ cells themselves
play no part in the production of testosterone. Clearly,
therefore, a disruption of spermatogenesis will produce no
effect on the output of androgens.
This is in contradistinction to the female gonad where
the germ cell development and hormone production are
closely interrelated.
The Ovary
The germinal epithelium in the ovary, by creating the
primordial follicle, accounts for both the ovum and the
cells producing oestrogen and progesterone.
The normal cycle within the ovary commences with the
ingrowth of a group of cells from the germinal epithelium.
These develop to form the primordial follicle containing
the oocyte and the membrana granulosa and theca interna.
The latter are responsible for the production of oestrogen,
which is partly secreted into the circulation and partly
stored in the liquor.
The mature or Graafian follicle, after rupturing and ex-
pelling the ovum, develops into the corpus luteum - the
progesterone factory. The early development of the germ
cells is by a process of mitosis up until the formation of
the primary oocyte. During this period of mitotic activity,
sensitivity to irradiation is high. The primary oocyte which
undergoes reduction division by meiosis i3 also considered
radiosensitive, to a degree which varies from species to
species. Its tolerance in humans is not known.
As the ovum ages into the Graafian form, it becomes
more resistant to the injurious effects of irradiation. This
is not true of the granulosa cells which appear to be more
sensitive in the Graafian follicle than in the primordial
follicle: Most of these data are derived from work done
on rabbits, where a single dose of 1 200 rads is sufficient
to arrest oogenesis. The mlllimum dose required to pro-
duce the same effect in the human is uncertain but is
known to depend on the age of the woman. While a dose
of 400 - 500 rads may be sufficient to produce permanent
arrest of the menses in a 40-year-old woman, a dose of
I 200 - 2 000 rads will be required to give the same result
in a young female.
Therefore, ionising irradiation 'applied in relatively low
doses to the female pelvis will result in a twofold effect of
radiation castration, comprising both sterility and pre-
mature menopause. This is complete, as can be demon-
strated by urinary excretion studies which show a reduction
of oestrogen after irradiation which is not further affected
by surgical oophorectomy: While this is obviously a dis-
advantage for women subjected to radiotherapy where the
ovaries, by virtue of their anatomical location, cannot be
shielded, it can be of benefit to the patient with advanced
breast carcinoma, where surgery is contra-indicated.
We have seen that the gonads are composed of tissues
of widely varying radiosensitivity, the extremely sensitive
and the more tolerant, a distinction of great importance to
the radiotherapist. Tumours arising from these tissues ap-
pear to inherit a similar degree of radiation response,
making both the seminoma and the dysgerminoma a group
of tumours readily curable by radiotherapy.
The Genetic Effect
The genetic effect of irradiation and its risk to mankind
presents, in theory anyway, disturbing possibilities. The
study of this subject is too involved and cannot fall within
the scope of this discussion. Perhaps one might mention
that observations on the mutagenic effect of irradiation in
man have been directed at a number of groups," viz.:
radiologists; survivors of the Hiroshima and Nagasaki
bombing; French men and women receiving X-ray therapy
for sciatic neuralgia and other ailments; and women
treated for sterility by ovarian irradiation.
The yardsticks used to elicit genetic effects included
altered sex ratio in the offspring; congenital malformations;
fetal and infant mortality; infant birth mass; and anthro-
pometric measurements.
Little reliable evidence of a genetic effect of radiation
has emerged from these studies. Animal experimentation,
however, definitely demonstrates a mutagenic effect. In
the testes, the early spermatids appear to be most suscep-
tible to genetic damage. In the ovary it is the oocyte which
is least tolerant, but fortunately at a dose which almost
certainly induces sterility and so the risk is unlikely to
manifest in the offspring.
It would be foolhardy to expect that man is an excep-
tion to this observed effect. Until such time as sufficient
evidence accumulates to permit adequate appraisal of the
problem, we would be wise to take whatever steps are
necessary to reduce the prevailing rates of exposure.
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